TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
PMVP

Pmv Pharmaceuticals Inc

Healthcare · Biotechnology

1.30$ -2.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow PMVP
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – –
– +14.8% -18.0% -3.5% +2.6% +299.0% -9.0% -88.4%
– -15.8% +112.9% +176.3% +90.9% +21.4% -28.3% -33.2%
– -29.4% +127.8% +207.2% +47.6% – – –
– +201.6% -144.0% – -113.8% – -129.3% –
– -75.9% +35.8% +811.5% +491.8% -88.0% -31.9% -95.6%
– -85.1% +763.9% -614.4% -99.0% +3,594.8% – +31.5%
– – – -99.3% -52.6% – – –
– +0.0% +374.0% -99.3% -52.6% +3,613.7% -99.1% +61.3%
– +559.6% +570.6% -165.3% – – – -223.2%
– – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?